Noninvasive diagnosis of renovascular disease

V. J. Canzanello, Stephen C Textor

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Objective: To present the epidemiologic and clinical features of renovascular disease and discuss various diagnostic approaches. Design: We describe the findings in patients with fibromuscular dysplasia or atherosclerotic disease of the renal arteries and review pertinent studies from the literature. Results: Renovascular disease is an important cause of resistant hypertension and progressive renal insufficiency, particularly in the elderly population. Improved blood pressure control and renal function after revascularization have generated intense interest in identifying those patients likely to benefit from this intervention. Fibromuscular dysplasia and atherosclerotic renal artery stenosis account for most cases of renovascular disease. Both entities produce resistant hypertension; the latter is the more common cause of progressive renal insufficiency- occasionally leading to end-stage renal disease. Angiotensin-converting enzyme inhibitor-related renal dysfunction, otherwise unexplained renal insufficiency, and recurrent pulmonary edema are increasingly recognized clinical manifestations of renovascular disease. Traditional screening tests such as intravenous pyelography, intravenous digital subtraction angiography, radionuclide scintirenography, and measurement of the peripheral venous plasma renin activity have limited accuracy for diagnosing renal artery stenosis and do not accurately predict the blood pressure response to revascularization. In comparison, recently developed noninvasive tests such as captopril renography, renal artery duplex sonography, and magnetic resonance angiography seem to be more accurate and, in the case of captopril renography, may be more predictive of the blood pressure response to revascularization. Conclusion: Future directions in the area of renovascular disease should include a direct comparison among these new noninvasive diagnostic techniques, with a particular focus on the identification of those patients most likely to benefit from revascularization in terms of both blood pressure control and improved renal function.

Original languageEnglish (US)
Pages (from-to)1172-1181
Number of pages10
JournalMayo Clinic Proceedings
Volume69
Issue number12
StatePublished - 1994

Fingerprint

Fibromuscular Dysplasia
Radioisotope Renography
Blood Pressure
Renal Insufficiency
Renal Artery Obstruction
Captopril
Renal Artery
Kidney
Hypertension
Digital Subtraction Angiography
Urography
Magnetic Resonance Angiography
Pulmonary Edema
Angiotensin-Converting Enzyme Inhibitors
Renin
Radioisotopes
Chronic Kidney Failure
Ultrasonography
Population
Direction compound

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Noninvasive diagnosis of renovascular disease. / Canzanello, V. J.; Textor, Stephen C.

In: Mayo Clinic Proceedings, Vol. 69, No. 12, 1994, p. 1172-1181.

Research output: Contribution to journalArticle

Canzanello, VJ & Textor, SC 1994, 'Noninvasive diagnosis of renovascular disease', Mayo Clinic Proceedings, vol. 69, no. 12, pp. 1172-1181.
Canzanello, V. J. ; Textor, Stephen C. / Noninvasive diagnosis of renovascular disease. In: Mayo Clinic Proceedings. 1994 ; Vol. 69, No. 12. pp. 1172-1181.
@article{ac2e51c6e9f14bf5ade971b0e5ebd2a3,
title = "Noninvasive diagnosis of renovascular disease",
abstract = "Objective: To present the epidemiologic and clinical features of renovascular disease and discuss various diagnostic approaches. Design: We describe the findings in patients with fibromuscular dysplasia or atherosclerotic disease of the renal arteries and review pertinent studies from the literature. Results: Renovascular disease is an important cause of resistant hypertension and progressive renal insufficiency, particularly in the elderly population. Improved blood pressure control and renal function after revascularization have generated intense interest in identifying those patients likely to benefit from this intervention. Fibromuscular dysplasia and atherosclerotic renal artery stenosis account for most cases of renovascular disease. Both entities produce resistant hypertension; the latter is the more common cause of progressive renal insufficiency- occasionally leading to end-stage renal disease. Angiotensin-converting enzyme inhibitor-related renal dysfunction, otherwise unexplained renal insufficiency, and recurrent pulmonary edema are increasingly recognized clinical manifestations of renovascular disease. Traditional screening tests such as intravenous pyelography, intravenous digital subtraction angiography, radionuclide scintirenography, and measurement of the peripheral venous plasma renin activity have limited accuracy for diagnosing renal artery stenosis and do not accurately predict the blood pressure response to revascularization. In comparison, recently developed noninvasive tests such as captopril renography, renal artery duplex sonography, and magnetic resonance angiography seem to be more accurate and, in the case of captopril renography, may be more predictive of the blood pressure response to revascularization. Conclusion: Future directions in the area of renovascular disease should include a direct comparison among these new noninvasive diagnostic techniques, with a particular focus on the identification of those patients most likely to benefit from revascularization in terms of both blood pressure control and improved renal function.",
author = "Canzanello, {V. J.} and Textor, {Stephen C}",
year = "1994",
language = "English (US)",
volume = "69",
pages = "1172--1181",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "12",

}

TY - JOUR

T1 - Noninvasive diagnosis of renovascular disease

AU - Canzanello, V. J.

AU - Textor, Stephen C

PY - 1994

Y1 - 1994

N2 - Objective: To present the epidemiologic and clinical features of renovascular disease and discuss various diagnostic approaches. Design: We describe the findings in patients with fibromuscular dysplasia or atherosclerotic disease of the renal arteries and review pertinent studies from the literature. Results: Renovascular disease is an important cause of resistant hypertension and progressive renal insufficiency, particularly in the elderly population. Improved blood pressure control and renal function after revascularization have generated intense interest in identifying those patients likely to benefit from this intervention. Fibromuscular dysplasia and atherosclerotic renal artery stenosis account for most cases of renovascular disease. Both entities produce resistant hypertension; the latter is the more common cause of progressive renal insufficiency- occasionally leading to end-stage renal disease. Angiotensin-converting enzyme inhibitor-related renal dysfunction, otherwise unexplained renal insufficiency, and recurrent pulmonary edema are increasingly recognized clinical manifestations of renovascular disease. Traditional screening tests such as intravenous pyelography, intravenous digital subtraction angiography, radionuclide scintirenography, and measurement of the peripheral venous plasma renin activity have limited accuracy for diagnosing renal artery stenosis and do not accurately predict the blood pressure response to revascularization. In comparison, recently developed noninvasive tests such as captopril renography, renal artery duplex sonography, and magnetic resonance angiography seem to be more accurate and, in the case of captopril renography, may be more predictive of the blood pressure response to revascularization. Conclusion: Future directions in the area of renovascular disease should include a direct comparison among these new noninvasive diagnostic techniques, with a particular focus on the identification of those patients most likely to benefit from revascularization in terms of both blood pressure control and improved renal function.

AB - Objective: To present the epidemiologic and clinical features of renovascular disease and discuss various diagnostic approaches. Design: We describe the findings in patients with fibromuscular dysplasia or atherosclerotic disease of the renal arteries and review pertinent studies from the literature. Results: Renovascular disease is an important cause of resistant hypertension and progressive renal insufficiency, particularly in the elderly population. Improved blood pressure control and renal function after revascularization have generated intense interest in identifying those patients likely to benefit from this intervention. Fibromuscular dysplasia and atherosclerotic renal artery stenosis account for most cases of renovascular disease. Both entities produce resistant hypertension; the latter is the more common cause of progressive renal insufficiency- occasionally leading to end-stage renal disease. Angiotensin-converting enzyme inhibitor-related renal dysfunction, otherwise unexplained renal insufficiency, and recurrent pulmonary edema are increasingly recognized clinical manifestations of renovascular disease. Traditional screening tests such as intravenous pyelography, intravenous digital subtraction angiography, radionuclide scintirenography, and measurement of the peripheral venous plasma renin activity have limited accuracy for diagnosing renal artery stenosis and do not accurately predict the blood pressure response to revascularization. In comparison, recently developed noninvasive tests such as captopril renography, renal artery duplex sonography, and magnetic resonance angiography seem to be more accurate and, in the case of captopril renography, may be more predictive of the blood pressure response to revascularization. Conclusion: Future directions in the area of renovascular disease should include a direct comparison among these new noninvasive diagnostic techniques, with a particular focus on the identification of those patients most likely to benefit from revascularization in terms of both blood pressure control and improved renal function.

UR - http://www.scopus.com/inward/record.url?scp=0028154886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028154886&partnerID=8YFLogxK

M3 - Article

C2 - 7967780

AN - SCOPUS:0028154886

VL - 69

SP - 1172

EP - 1181

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 12

ER -